BRIEF-AstraZeneca Provides Update on Evusheld US EUA
AstraZeneca PLC: * UPDATE ON EVUSHELD US EUA
* TO CONTINUE TO WORK WITH FDA, OTHER HEALTH AUTHORITIES TO COLLECT, ASSESS, SHARE RELEVANT DATA REGARDING EVUSHELD AND SARS-COV-2 VARIANTS * EVUSHELD REMAINS AUTHORISED IN OTHER COUNTRIES WHERE IT IS APPROVED FOR COVID PRE-EXPOSURE PROPHYLAXIS,TREATMENT, INCLUDING EU AND JAPAN Source text for Eikon: Further company coverage:
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- JAPAN
- AstraZeneca PLC
- Eikon
- ASSESS
ALSO READ
Bond Markets Reel as Japan Races into Election Spending Frenzy
Japan's Political Showdown: Takaichi's Bold Economic Gamble
UPDATE 2-Chinese exports of rare earth magnets to Japan fall in December
India-Japan Economic Collaboration Surges: A New Era of Investment and Innovation
China December rare earth magnets exports to Japan down 8% on month
Google News